A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.
Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936)
The fourth planet in order from the sun. Its two natural satellites are Deimos and Phobos. It is one of the four inner or terrestrial planets of the solar system.
A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed)
Drugs used to prevent SEIZURES or reduce their severity.
A family of intestinal flukes of the class Trematoda which occurs in animals and man. Some of the genera are Heterophyes, Metagonimus, Cryptocotyle, Stellantchasmus, and Euryhelmis.
A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.
The environment outside the earth or its atmosphere. The environment may refer to a closed cabin (such as a space shuttle or space station) or to space itself, the moon, or other planets.
Inorganic compounds that contain magnesium as an integral part of the molecule.
A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
A variety of anesthetic methods such as EPIDURAL ANESTHESIA used to control the pain of childbirth.
Magnesium oxide (MgO). An inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.
Infections caused by infestation with worms of the class Trematoda.
Maternal deaths resulting from complications of pregnancy and childbirth in a given population.
Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE).

Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. (1/407)

A number of studies have demonstrated that magnesium salts given after traumatic brain injury improve subsequent neurologic outcome. However, given that these earlier studies have used a number of different salts, dosages, and routes of administration, follow-up studies of the neuroprotective properties of magnesium are complicated, with comparisons to the earlier literature virtually impossible. The present study has therefore characterized the dose-response characteristics of the most commonly used sulfate and chloride salts of magnesium in a severe model of diffuse traumatic axonal injury in rats. Both magnesium salts improved neurologic outcome in rats when administered as a bolus at 30 min after injury. The i.v. and i.m. optima of each salt was 250 micromol/kg and 750 micromol/kg, respectively. The identical concentrations required for improved neurologic outcome suggest that improvement in outcome was dependent on the magnesium cation and not the associated anion. Subsequent magnetic resonance studies demonstrated that the administered magnesium penetrated the blood-brain barrier after injury and resulted in an increased brain intracellular free magnesium concentration and associated bioenergetic state as reflected in the cytosolic phosphorylation potential. Both of these metabolic parameters positively correlated with resultant neurologic outcome measured daily in the same animals immediately before the magnetic resonance determinations.  (+info)

Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. (2/407)

AIMS: Magnesium treatment suppresses ventricular arrhythmias in acute myocardial infarction and possibly mortality after infarction, but the underlying mechanisms are inadequately understood. We tested whether the effect of magnesium could be attributed to an influence on the autonomic control of the heart, changes in disturbed repolarization, relief of ischaemia or limitation of myocardial injury. METHODS AND RESULTS: Fifty-nine consecutive patients with acute myocardial infarction were randomized to receive 70 mmol of magnesium (n = 31) infused over 24 h or placebo (n = 26). Occurrence of ventricular arrhythmias and heart rate variability (SD of 5-min mean sinus beat intervals over a 24 h period, SDANN; low frequency/high frequency amplitude ratio, LF/HF ratio), and the number of ischaemic episodes on vectorcardiography were measured from the first day of treatment. QT dispersion corrected for heart rate was measured from the 12-lead ECG. Magnesium decreased the number of hourly ventricular premature beats (P < 0.001) and the number of ventricular tachycardias (P < 0.05). QT dispersion corrected for heart rate was decreased in both measurements at 24 h and 1 week (P < 0.001). SDANN and LF/HF ratio were unchanged. The number of ischaemic episodes on vectorcardiography were equal, and peak creatine kinase MB release did not differ between the groups. In testing the pathophysiological mechanisms, serum magnesium levels after infusion correlated with hourly ventricular premature beats (rs = -0.47; P < 0.01), ventricular tachycardias (rs = -0.26; P < 0.05), and QT dispersion corrected for heart rate (rs = -0.75; P < 0.001), but not with SDANN, LF/HF ratio or peak creatine kinase MB. QT dispersion corrected for heart rate correlated with hourly ventricular premature beats (rs = 0.48; P < 0.001) and ventricular tachycardias (rs = 0.27; P < 0.05). CONCLUSIONS: Magnesium suppresses early ventricular arrhythmias in acute myocardial infarction. The decreased arrhythmicity is related to enhancement of homogeneity in repolarization, but not to attenuation of prevailing ischaemia, improvement of autonomic nervous derangements or myocardial salvage.  (+info)

Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique. (3/407)

There is evidence to suggest that magnesium (Mg2+) is beneficial in the treatment of a number of conditions, including pre-eclampsia and acute myocardial infarction. The mode of action of Mg2+ in these conditions is not clear, although the vasodilator properties of Mg2+ are well documented both in vitro and in vivo. Previously, we demonstrated that i.v. infusion of magnesium sulphate (MgSO4) alone, or in the presence of vasoconstrictors, caused increases in flow and conductance in the common carotid, internal carotid and hindquarters vascular beds, in conscious rats. Therefore, the objective of the present study was to investigate the regional and subregional changes in haemodynamics in response to the vasoconstrictor peptide endothelin-1 (ET-1) and MgSO4 in more detail, using the coloured microsphere reference technique. Infusion of ET-1 and MgSO4 had similar effects on heart rate and mean arterial pressure as in our previous study. Infusion of ET-1 caused a rise in mean arterial pressure and a fall in heart rate, and infusion of MgSO4 returned mean arterial pressure to control levels with no effect on heart rate. The responses to MgSO4 in the presence of ET-1 showed considerable regional heterogeneity with blood flow increasing (e.g. skeletal muscle), decreasing (e.g. stomach) or not changing (e.g. kidney). Of particular interest was the finding that MgSO4 caused increases in flow in the cerebral and coronary vascular beds. This, and our previous studies, have shown that MgSO4 can reverse vasoconstriction in a number of vascular beds, and indicate that this compound may have therapeutic benefit in conditions associated with vasospasm.  (+info)

Effects of temperature, Mg2+ concentration and mismatches on triplet-repeat expansion during DNA replication in vitro. (4/407)

The human genome contains many simple tandem repeats that are widely dispersed and highly polymorphic. At least one group of simple tandem repeats, the DNA trinucleotide repeats, can dramaticallyexpand in size during transmission from one generation to the next to cause disease by a process known as dynamic mutation. We investigated the ability of trinucleotide repeats AAT and CAG to expand in size during DNA replication using a minimal in vitro system composed of the repeat tract, with and without unique flanking sequences, and DNA polymerase. Varying Mg2+concentration and temperature gave dramatic expansions of repeat size during DNA replication in vitro. Expansions of up to 1000-fold were observed. Mismatches partially stabilized the repeat tracts against expansion. Expansions were only detected when the primer was complementary to the repeat tract rather than the flanking sequence. The results imply that cellular environment and whether the growing strand contains a nick or gap are important factors for the expansion process in vivo.  (+info)

Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine. (5/407)

We have investigated the dose-effect relationship of neostigmine in antagonizing vecuronium-induced neuromuscular block with and without magnesium sulphate (MgSO4) pretreatment. Neuromuscular block was assessed by electromyography with train-of-four (TOF) stimulation. First, we determined neostigmine-induced recovery in patients pretreated with MgSO4 (group A) or saline (group B) (n = 12 each). The height of T1, 5 min after neostigmine, was 43 (7)% in group A and 65 (6)% in group B (P < 0.01). Respective values after 10 min were 59 (7)% and 83 (5)% (P < 0.01). TOF ratio, 5 min after neostigmine, was 29 (6)% in group A and 29 (5)% in group B. Respective values after 10 min were 38 (11)% and 51 (7)% (P < 0.01). To gain insight into the mechanisms leading to delayed recovery after MgSO4, we calculated assisted recovery, defined as neostigmine-induced recovery minus mean spontaneous recovery. Spontaneous recovery was assessed in another 24 patients. Patients in group C received MgSO4/vecuronium and patients in group D vecuronium only (n = 12 each). Five minutes after neostigmine, assisted recovery was 22 (7)% in the MgSO4 pretreated patients and 28 (6)% in controls (P < 0.05). Ten minutes after neostigmine, values were 24 (7)% and 22 (6)%. Maximum assisted recovery was not influenced by MgSO4 pretreatment (27 (6)% in group A and 32 (6)% in group B) and time to maximum effect was comparable between groups: 6 (4-10) min and 7 (5-8) min, respectively. We conclude that neostigmine-induced recovery was attenuated in patients treated with MgSO4. This was mainly a result of slower spontaneous recovery and not decreased response to neostigmine.  (+info)

Spontaneous labour at term is associated with fetal monocyte activation. (6/407)

The aetiology of both term and preterm labour remains incompletely understood. Maternal infectious diseases as well as intra-uterine infections were shown to be a well established cause of uncontrollable preterm delivery, indicating that inflammatory reactions, regulated by maternal immunecompetent cells, are implicated in labour-promoting mechanisms. To investigate the possibility that the activation of the fetal immune system may be involved in labour induction, we examined cytokine production patterns of different cord blood cell populations obtained from neonates after spontaneous onset of normal term labour and vaginal delivery (n = 25), vaginal delivery but induced term labour (n = 17), and preterm delivery because of uncontrollable labour (n = 27, 20 patients received corticoid treatment for fetal lung maturation), in comparison with cells obtained from neonates after elective term caesarean delivery in the absence of labour (n = 15). Our results demonstrate that spontaneous term labour, but not induced term labour, was associated with significantly increased IL-6 production by myelomonocytic cell populations. Preterm delivery due to uncontrollable labour with resistance to tocolysis was not associated with increased IL-6 production by fetal myelomonocytic cells. Two-colour flow cytometry combined with intracellular cytokine staining was used to identify fetal monocytes as sources of labour-associated IL-6 release at term. We did not find any activation of cord blood T cells in association with spontaneous term or uncontrollable preterm labour. Therefore, fetal T cell responses may not cause monocyte activation. Our results suggest that increased release of IL-6 from fetal monocytes is involved in mechanisms promoting normal term, but not preterm labour, and that mechanisms inducing term and preterm labour are completely different.  (+info)

Developmental change in magnesium sulfate-induced relaxation of rabbit pulmonary arteries. (7/407)

Magnesium causes a variety of vascular smooth muscle to relax. The present study was designed to determine whether there is a developmental change in the magnesium-induced response of pulmonary vasculature. Isolated pulmonary arteries (PA) of newborn (1- to 3-day-old) and juvenile (4- to 6-wk-old) rabbits were suspended in organ chambers filled with modified Krebs-Ringer bicarbonate solution (95% O(2)-5% CO(2), 37.0 degrees C), and their isometric tension was recorded. In arteries preconstricted with endothelin-1 to a similar tension level, MgSO(4) caused greater relaxation of juvenile rabbit PA than that of the newborn rabbit PA. Verapamil, a voltage-dependent Ca(2+) channel blocker, attenuated magnesium-induced relaxation in juvenile rabbit PA but not in newborn PA. The uptake of Ca(2+) of juvenile rabbit PA was inhibited by MgSO(4), and the inhibition was attenuated by verapamil. The uptake of Ca(2+) of newborn rabbit PA was smaller than that of the juvenile PA and was not significantly affected by MgSO(4) and verapamil. These results demonstrate that there is a developmental increase in the dilator effect of MgSO(4) in rabbit PA. In newborn rabbit PA, an incomplete maturation of the voltage-dependent Ca(2+) channels may contribute to the smaller vasodilation induced by MgSO(4).  (+info)

Efficacy of various chemotherapeutic agents on the growth of Spironucleus vortens, an intestinal parasite of the freshwater angelfish. (8/407)

Seven chemotherapeutic agents (dimetridazole, metronidazole, pyrimethamine, albendazole, fenbendazole, mebendazole and magnesium sulfate) were examined for growth inhibition on the cultivation of Spironucleus vortens. Dimetridazole and metronidazole were effective in inhibiting the parasite's growth. At concentrations of 1 microgram ml-1 or higher, both dramatically decreased numbers of parasites. At 24 h exposure, 33% of parasites were inhibited when exposed to dimetridazole or metronidazole at concentrations of 2 and 4 micrograms ml-1, respectively. Dimetridazole at 4 micrograms ml-1 or higher concentrations decreased the number of organisms to 50% or less after 48 h exposure. During the same period of time, the numbers of parasites decreased to 50% or less when exposed to metronidazole at 6 micrograms ml-1 or higher. Pyrimethamine at concentrations of 1 to 10 micrograms ml-1 was not effective in inhibiting the parasite's growth. Albendazole and fenbendazole at concentrations of 0.1 and 0.5 microgram ml-1 were similar in inhibiting the growth of the organism. Both compounds suppressed parasite growth at concentrations of 1.0 microgram ml-1 or higher after 24 h exposure. Mebendazole inhibited the parasite's growth at concentrations of 0.5 microgram ml-1 or higher. At 72 h exposure, 45 to 50% of the parasites were inhibited when exposed to mebendazole at concentrations higher than 0.5 microgram ml-1. Magnesium sulfate at concentrations of 70 mg ml-1 or higher also suppressed the growth of parasites after 24 h exposure. These results indicate that dimetridazole, metronidazole and mebendazole are the most effective chemotherapeutic agents in vitro at inhibiting the growth of S. vortens.  (+info)

Magnesium Sulfate is an inorganic salt with the chemical formula MgSO4. It is often encountered as the heptahydrate sulfate mineral epsomite (MgSO4ยท7H2O), commonly called Epsom salts. Magnesium sulfate is used medically as a vasodilator, to treat constipation, and as an antidote for magnesium overdose or poisoning. It is also used in the preparation of skin for esthetic procedures and in the treatment of eclampsia, a serious complication of pregnancy characterized by seizures.

Tocolytic agents are a type of medication used in obstetrics to suppress premature labor. They work by relaxing the smooth muscle of the uterus, thereby reducing contractions and delaying delivery. Commonly used tocolytic agents include beta-adrenergic agonists (such as terbutaline), calcium channel blockers (such as nifedipine), and prostaglandin synthesis inhibitors (such as indomethacin). It's important to note that the use of tocolytic agents is typically reserved for specific clinical situations, and their benefits must be weighed against potential risks to both the mother and fetus.

Eclampsia is a serious pregnancy complication characterized by the onset of seizures or convulsions in a woman who has already developed preeclampsia, which is a condition marked by high blood pressure and damage to organs such as the liver and kidneys. Eclampsia can occur before, during, or after delivery and is considered a medical emergency that requires immediate treatment. It can pose significant risks to both the mother and the baby, including premature birth, fetal growth restriction, and even maternal and fetal death.

The exact causes of eclampsia are not fully understood, but it is thought to be related to problems with the placenta and abnormal blood vessel development in the uterus. Risk factors for developing eclampsia include preexisting medical conditions such as chronic hypertension or diabetes, a history of preeclampsia or eclampsia in previous pregnancies, multiple gestation (carrying more than one baby), and certain genetic factors.

Treatment for eclampsia typically involves delivering the baby as soon as possible to prevent further complications. In some cases, medication may be given to manage seizures and prevent their recurrence. Close monitoring of both the mother and the baby is essential to ensure the best possible outcomes.

Magnesium is an essential mineral that plays a crucial role in various biological processes in the human body. It is the fourth most abundant cation in the body and is involved in over 300 enzymatic reactions, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Magnesium also contributes to the structural development of bones and teeth.

In medical terms, magnesium deficiency can lead to several health issues, such as muscle cramps, weakness, heart arrhythmias, and seizures. On the other hand, excessive magnesium levels can cause symptoms like diarrhea, nausea, and muscle weakness. Magnesium supplements or magnesium-rich foods are often recommended to maintain optimal magnesium levels in the body.

Some common dietary sources of magnesium include leafy green vegetables, nuts, seeds, legumes, whole grains, and dairy products. Magnesium is also available in various forms as a dietary supplement, including magnesium oxide, magnesium citrate, magnesium chloride, and magnesium glycinate.

Magnesium deficiency, also known as hypomagnesemia, is a condition characterized by low levels of magnesium in the blood. Magnesium is an essential mineral that plays a crucial role in many bodily functions, including muscle and nerve function, heart rhythm, bone strength, and immune system regulation.

Hypomagnesemia can occur due to various factors, such as poor dietary intake, malabsorption syndromes, chronic alcoholism, diabetes, certain medications (such as diuretics), and excessive sweating or urination. Symptoms of magnesium deficiency may include muscle cramps, tremors, weakness, heart rhythm abnormalities, seizures, and mental status changes.

It is important to note that mild magnesium deficiency may not cause any symptoms, and the diagnosis typically requires blood tests to measure magnesium levels. Treatment for hypomagnesemia usually involves oral or intravenous magnesium supplementation, along with addressing the underlying causes of the deficiency.

I'm sorry for any confusion, but "Mars" is not a medical term. It is the fourth planet from the Sun in our solar system and is often called the "Red Planet" due to its reddish appearance from iron oxide (rust) on its surface. If you have any medical questions or terms you would like defined, I'd be happy to help!

Pre-eclampsia is a pregnancy-related disorder, typically characterized by the onset of high blood pressure (hypertension) and damage to organs, such as the kidneys, after the 20th week of pregnancy. It is often accompanied by proteinuria, which is the presence of excess protein in the urine. Pre-eclampsia can lead to serious complications for both the mother and the baby if left untreated or unmanaged.

The exact causes of pre-eclampsia are not fully understood, but it is believed that placental issues, genetic factors, and immune system problems may contribute to its development. Risk factors include first-time pregnancies, history of pre-eclampsia in previous pregnancies, chronic hypertension, obesity, older age (35 or older), and assisted reproductive technology (ART) pregnancies.

Pre-eclampsia can progress to a more severe form called eclampsia, which is characterized by the onset of seizures. HELLP syndrome, another severe complication, involves hemolysis (breaking down of red blood cells), elevated liver enzymes, and low platelet count.

Early detection and management of pre-eclampsia are crucial to prevent severe complications. Regular prenatal care, including frequent blood pressure checks and urine tests, can help identify early signs of the condition. Treatment typically involves close monitoring, medication to lower blood pressure, corticosteroids to promote fetal lung maturity, and, in some cases, delivery of the baby if the mother's or baby's health is at risk.

Drug incompatibility refers to a situation where two or more drugs cannot be mixed, combined, or administered together because they will interact in a way that reduces their effectiveness, causes unintended side effects, or even results in harm to the patient. This can occur due to chemical reactions between the drugs, physical interactions (such as precipitation), or pharmacological interactions (such as one drug inhibiting the metabolism of another).

Drug incompatibilities can be identified through various methods, including laboratory testing, literature review, and clinical experience. Healthcare professionals must be aware of potential drug incompatibilities and take steps to avoid them when prescribing or administering medications to patients. This may involve using different administration routes, changing the timing of medication administration, or selecting alternative drugs that are compatible with each other.

Anticonvulsants are a class of drugs used primarily to treat seizure disorders, also known as epilepsy. These medications work by reducing the abnormal electrical activity in the brain that leads to seizures. In addition to their use in treating epilepsy, anticonvulsants are sometimes also prescribed for other conditions, such as neuropathic pain, bipolar disorder, and migraine headaches.

Anticonvulsants can work in different ways to reduce seizure activity. Some medications, such as phenytoin and carbamazepine, work by blocking sodium channels in the brain, which helps to stabilize nerve cell membranes and prevent excessive electrical activity. Other medications, such as valproic acid and gabapentin, increase the levels of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which has a calming effect on nerve cells and helps to reduce seizure activity.

While anticonvulsants are generally effective at reducing seizure frequency and severity, they can also have side effects, such as dizziness, drowsiness, and gastrointestinal symptoms. In some cases, these side effects may be managed by adjusting the dosage or switching to a different medication. It is important for individuals taking anticonvulsants to work closely with their healthcare provider to monitor their response to the medication and make any necessary adjustments.

Heterophyidae is a family of small intestinal fluke parasites, which are trematodes. These parasites have a complex life cycle involving one or two intermediate hosts, usually snails and fish, before infecting the definitive host - a mammal, bird, or reptile. The most common species that infect humans include Heterophyes heterophyes, Metagonimus yokogawai, and Haplorchis taichui.

Human infection typically occurs through the consumption of raw or undercooked fish containing metacercariae (the infective stage). Once ingested, the metacercariae excyst in the small intestine, where they mature into adults and attach to the intestinal wall. The adult flukes are relatively small, usually less than 2 mm in length, and feed on blood and tissue fluids from the host's intestinal mucosa.

Light infections may be asymptomatic or cause mild gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, or vomiting. Heavy infections can lead to more severe complications, including intestinal obstruction, malabsorption, and anemia due to blood loss. In some cases, the infection may disseminate to other organs, causing extraintestinal manifestations such as hepatomegaly (enlarged liver), splenomegaly (enlarged spleen), or pulmonary symptoms if larvae migrate to the lungs.

Prevention of heterophyidiasis involves avoiding the consumption of raw or undercooked fish, especially in endemic areas. Proper cooking and freezing techniques can effectively kill metacercariae and prevent infection. Infected individuals should receive appropriate medical treatment with anti-parasitic drugs such as praziquantel to eliminate the parasites and alleviate symptoms.

Heparin sulfate is not exactly referred to as "heparitin sulfate" in medical terminology. The correct term is heparan sulfate, which is a type of glycosaminoglycan (GAG), a long unbranched chain of repeating disaccharide units composed of a hexuronic acid and a hexosamine.

Heparan sulfate is found on the cell surface and in the extracellular matrix, where it plays crucial roles in various biological processes, including cell signaling, regulation of growth factor activity, and control of blood coagulation. It is also an important component of the proteoglycans, which are complex molecules that help to maintain the structural integrity and function of tissues and organs.

Like heparin, heparan sulfate has a high negative charge due to the presence of sulfate groups, which allows it to bind to and interact with various proteins and growth factors. However, heparan sulfate has a more diverse structure than heparin, with variations in the pattern of sulfation along the chain, which leads to specificity in its interactions with different proteins.

Defects in heparan sulfate biosynthesis or function have been implicated in various human diseases, including certain forms of cancer, developmental disorders, and infectious diseases.

The term "extraterrestrial environment" is not typically used in a medical context, but rather in the fields of astronomy and astrobiology. It generally refers to any physical environment outside of Earth, including the surfaces and atmospheres of other planets, moons, asteroids, comets, and interstellar space.

In a broader sense, one might use the term "extraterrestrial environment" to refer to any physical conditions that are not found naturally on Earth, such as extreme temperatures, radiation levels, or atmospheric compositions. However, this is not a standard medical definition.

It's worth noting that there may be potential health implications for humans who travel to extraterrestrial environments, as they would be exposed to new and potentially hazardous conditions. As such, space medicine is a growing field of research that aims to understand and mitigate the health risks associated with space travel.

Magnesium compounds refer to substances that contain magnesium (an essential mineral) combined with other elements. These compounds are formed when magnesium atoms chemically bond with atoms of other elements. Magnesium is an alkaline earth metal and it readily forms stable compounds with various elements due to its electron configuration.

Examples of magnesium compounds include:

1. Magnesium oxide (MgO): Also known as magnesia, it is formed by combining magnesium with oxygen. It has a high melting point and is used in various applications such as refractory materials, chemical production, and agricultural purposes.
2. Magnesium hydroxide (Mg(OH)2): Often called milk of magnesia, it is a common antacid and laxative. It is formed by combining magnesium with hydroxide ions.
3. Magnesium chloride (MgCl2): This compound is formed when magnesium reacts with chlorine gas. It has various uses, including as a de-icing agent, a component in fertilizers, and a mineral supplement.
4. Magnesium sulfate (MgSO4): Also known as Epsom salts, it is formed by combining magnesium with sulfur and oxygen. It is used as a bath salt, a laxative, and a fertilizer.
5. Magnesium carbonate (MgCO3): This compound is formed when magnesium reacts with carbon dioxide. It has various uses, including as a fire retardant, a food additive, and a dietary supplement.

These are just a few examples of the many different magnesium compounds that exist. Each compound has its unique properties and applications based on the elements it is combined with.

Cerebral palsy (CP) is a group of disorders that affect a person's ability to move and maintain balance and posture. According to the Mayo Clinic, CP is caused by abnormal brain development or damage to the developing brain that affects a child's ability to control movement.

The symptoms of cerebral palsy can vary in severity and may include:

* Spasticity (stiff or tight muscles)
* Rigidity (resistance to passive movement)
* Poor coordination and balance
* Weakness or paralysis
* Tremors or involuntary movements
* Abnormal gait or difficulty walking
* Difficulty with fine motor skills, such as writing or using utensils
* Speech and language difficulties
* Vision, hearing, or swallowing problems

It's important to note that cerebral palsy is not a progressive condition, meaning that it does not worsen over time. However, the symptoms may change over time, and some individuals with CP may experience additional medical conditions as they age.

Cerebral palsy is usually caused by brain damage that occurs before or during birth, but it can also be caused by brain injuries that occur in the first few years of life. Some possible causes of cerebral palsy include:

* Infections during pregnancy
* Lack of oxygen to the brain during delivery
* Traumatic head injury during birth
* Brain bleeding or stroke in the newborn period
* Genetic disorders
* Maternal illness or infection during pregnancy

There is no cure for cerebral palsy, but early intervention and treatment can help improve outcomes and quality of life. Treatment may include physical therapy, occupational therapy, speech therapy, medications to manage symptoms, surgery, and assistive devices such as braces or wheelchairs.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Obstetrical anesthesia refers to the use of anesthetic techniques and medications during childbirth or obstetrical procedures. The goal is to provide pain relief and comfort to the birthing person while ensuring the safety of both the mother and the baby. There are different types of obstetrical anesthesia, including:

1. Local anesthesia: Injection of a local anesthetic agent to numb a specific area, such as the perineum (the area between the vagina and the anus) during childbirth.
2. Regional anesthesia: Numbing a larger region of the body using techniques like spinal or epidural anesthesia. These methods involve injecting local anesthetic agents near the spinal cord to block nerve impulses, providing pain relief in the lower half of the body.
3. General anesthesia: Using inhaled gases or intravenous medications to render the birthing person unconscious during cesarean sections (C-sections) or other surgical procedures related to childbirth.

The choice of anesthetic technique depends on various factors, including the type of delivery, the mother's medical history, and the preferences of both the mother and the healthcare team. Obstetrical anesthesia requires specialized training and expertise to ensure safe and effective pain management during labor and delivery.

Magnesium oxide is an inorganic compound with the chemical formula MgO. It is a white, odorless solid that is highly basic and stable. Medically, magnesium oxide is used as a dietary supplement to prevent or treat low amounts of magnesium in the blood. It is also used as a antacid to neutralize stomach acid and as a laxative to relieve constipation.

Trematode infections, also known as trematodiasis or fluke infections, are parasitic diseases caused by various species of flatworms called trematodes. These parasites have an indirect life cycle involving one or two intermediate hosts (such as snails or fish) and a definitive host (usually a mammal or bird).

Humans can become accidentally infected when they consume raw or undercooked aquatic plants, animals, or contaminated water that contains the larval stages of these parasites. The most common trematode infections affecting humans include:

1. Schistosomiasis (also known as bilharzia): Caused by several species of blood flukes (Schistosoma spp.). Adult worms live in the blood vessels, and their eggs can cause inflammation and damage to various organs, such as the liver, intestines, bladder, or lungs.
2. Liver flukes: Fasciola hepatica and Fasciola gigantica are common liver fluke species that infect humans through contaminated watercress or other aquatic plants. These parasites can cause liver damage, abdominal pain, diarrhea, and eosinophilia (elevated eosinophil count in the blood).
3. Lung flukes: Paragonimus spp. are lung fluke species that infect humans through consumption of raw or undercooked crustaceans. These parasites can cause coughing, chest pain, and bloody sputum.
4. Intestinal flukes: Various species of intestinal flukes (e.g., Haplorchis spp., Metagonimus yokogawai) infect humans through consumption of raw or undercooked fish. These parasites can cause abdominal pain, diarrhea, and eosinophilia.
5. Eye fluke: The oriental eye fluke (Drepanotrema spp.) can infect the human eye through contaminated water. It can cause eye inflammation, corneal ulcers, and vision loss.

Prevention measures include avoiding consumption of raw or undercooked aquatic plants, animals, and their products; practicing good hygiene; and treating drinking water to kill parasites. Treatment typically involves administering anthelmintic drugs such as praziquantel, albendazole, or mebendazole, depending on the specific fluke species involved.

Maternal mortality is defined by the World Health Organization (WHO) as "the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes."

This definition highlights that maternal mortality is a preventable death that occurs during pregnancy, childbirth, or in the postpartum period, and it can be caused by various factors related to or worsened by the pregnancy or its management. The WHO also collects data on maternal deaths due to direct obstetric causes (such as hemorrhage, hypertensive disorders, sepsis, and unsafe abortion) and indirect causes (such as malaria, anemia, and HIV/AIDS).

Maternal mortality is a significant public health issue worldwide, particularly in low- and middle-income countries. Reducing maternal mortality is one of the Sustainable Development Goals (SDGs) set by the United Nations, with a target to reduce the global maternal mortality ratio to less than 70 per 100,000 live births by 2030.

Premature obstetric labor, also known as preterm labor, is defined as regular contractions leading to cervical changes that begin before 37 weeks of gestation. This condition can result in premature birth and potentially complications for the newborn, depending on how early the delivery occurs. It's important to note that premature labor requires medical attention and intervention to try to stop or delay it, if possible, to allow for further fetal development.

No FAQ available that match "magnesium sulfate"